Company: MDCXW
Filing Date: 2025-03-11
Form Type: 8-K
Source: 0001062993-25-005105
Chunk: 2

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-11
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01 Other Events.

On March 6, 2025, the Company issued a press release announcing the pricing of the Offering and on March 10, 2025, the Company issued a press release announcing the closing of the Offering.

Copies of the press releases are attached hereto as Exhibits 99.1 and 99.2, respectively, and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                                                                            
      No.                                                                                                                                                                             
      1.1      Placement Agency Agreement, dated as of March 6, 2025, by and between Medicus Pharma Ltd. and Maxim Group LLC as representative of the placement agents named therein  
      4.1      Form of Subscription Agreement (incorporated by reference from Exhibit 4.1 to the Company's Offering Statement on Form 1-A, filed with the SEC on February 28, 2025)   
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      4.2      Common Share Purchase Warrant                                                                                                                                          
      4.3      Warrant Agency Agreement, dated as of March 10, 2025, by and between Medicus Pharma Ltd. and Odyssey Transfer and Trust Company, as warrant agent                      
     99.1      Pricing Press Release, dated March 6, 2025                                                                                                                             
     99.2      Closing Press Release, dated March 10, 2025                                                                                                                            
    104.1      Cover Page Interactive Data File (embedded within the inline XBRL document).                                                                                           

Forward Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements include, but are not limited to, statements concerning regarding the Company's expected use of the net proceeds of the Offering. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements. In addition, forward-looking statements are typically identified by words such as "plan," "believe," "goal," "target," "aim," "expect," "anticipate," "intend," "outlook," "estimate